abilify aripiprazole tablet abilify aripiprazole solution abilify aripiprazole tablet orally disintegrating abilify aripiprazole injection solution
1 INDICATIONS AND USAGE ABILIFY (aripiprazole) Tablets are indicated for the treatment of: Schizophrenia Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder Adjunctive Treatment of Major Depressive Disorder Irritability Associated with Autistic Disorder Treatment of Tourette's Disorder ABILIFY is an atypical antipsychotic. ABILIFY is indicated for: Schizophrenia ( 14.1 ) Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder ( 14.2 ) Adjunctive Treatment of Major Depressive Disorder ( 14.3 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette's Disorder ( 14.5 )
otsuka america pharmaceutical, inc.
Related Pills
aripiprazole 5 MG Oral Tablet Abilify
otsuka america pharmaceutical, inc.
ABILIFY aripiprazole 15 MG Oral Tablet Abilify
Otsuka America Pharmaceutical, Inc.
ABILIFY aripiprazole 20 MG Oral Tablet Abilify
Otsuka America Pharmaceutical, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied ABILIFY ® (
ARIPIPRAZOLE) Tablets have markings on one side and are available in the strengths and packages listed in Table 28. Table 28: ABILIFY Tablet Presentations Tablet Strength Tablet Color/Shape Tablet Markings Pack Size NDC Code 2 mg green modified rectangle "A-006" and "2" Bottle of 30 59148-006-13 5 mg blue modified rectangle "A-007" and "5" Bottle of 30 Blister of 100 59148-007-13 59148-007-35 10 mg pink modified rectangle "A-008" and "10" Bottle of 30 Blister of 100 59148-008-13 59148-008-35 15 mg yellow round "A-009" and "15" Bottle of 30 Blister of 100 59148-009-13 59148-009-35 20 mg white round "A-010" and "20" Bottle of 30 Blister of 100 59148-010-13 59148-010-35 30 mg pink round "A-011" and "30" Bottle of 30 Blister of 100 59148-011-13 59148-011-35 Storage Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F)[see USP Controlled Room Temperature].
More pills like RECTANGLE A 006 2